, Singapore
327 views

Allied Technologies kills $130m deal with Lim Yew Ming

It will no longer buy Aik Chuan Construction and its subsidiaries.

Allied Technologies has terminated its memorandum of understanding (MOU) with Lim Yew Ming for the proposed acquisition of the entire issued share capital of Aik Chuan Construction and its subsidiaries for a total of $130m, a filing with the Singapore Exchange (SGX) revealed.

Allied Technologies has first received a letter of intent (LOI) for the proposed acquisition of the issued share capital from Lim Yew Ming in April. Lim Yew Ming represented in the LOI that he owned 100% of the entire issued share capital of Aik Chuan Construction, a development and dormitory operator which has been in operation since the 1980s and is said to have one of the largest dormitory operations in Singapore.

The total consideration would have comprised $30m and $50m to be paid in cash, whilst the balance consideration would have been satisfied by issuing and allotting new ordinary shares at a price not exceeding $0.01 apiece.

The MOU was mutually terminated by the parties with effect from 22 May.  

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.